State Street’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $395M | Buy |
16,063,046
+726,567
| +5% | +$16.8M | 0.01% | 686 |
|
|
2026
Q1 | $367M | Buy |
15,336,479
+285,941
| +2% | +$6.99M | 0.01% | 660 |
|
|
2025
Q4 | $341M | Sell |
15,050,538
-195,245
| -1% | -$4.25M | 0.01% | 698 |
|
|
2025
Q3 | $307M | Buy |
15,245,783
+6,118,927
| +67% | +$103M | 0.01% | 726 |
|
|
2025
Q2 | $130M | Sell |
9,126,856
-125,361
| -1% | -$1.47M | ﹤0.01% | 1165 |
|
|
2025
Q1 | $97.1M | Sell |
9,252,217
-1,169,859
| -11% | -$13.2M | ﹤0.01% | 1282 |
|
|
2024
Q4 | $126M | Buy |
10,422,076
+509,383
| +5% | +$6.67M | 0.01% | 1201 |
|
|
2024
Q3 | $146M | Buy |
9,912,693
+255,084
| +3% | +$3.55M | 0.01% | 1103 |
|
|
2024
Q2 | $139M | Sell |
9,657,609
-490,346
| -5% | -$7.83M | 0.01% | 1067 |
|
|
2024
Q1 | $165M | Sell |
10,147,955
-329,969
| -3% | -$5.16M | 0.01% | 984 |
|
|
2023
Q4 | $156M | Buy |
10,477,924
+835,361
| +9% | +$9.46M | 0.01% | 999 |
|
|
2023
Q3 | $108M | Sell |
9,642,563
-70,003
| -0.7% | -$813K | 0.01% | 1129 |
|
|
2023
Q2 | $97.7M | Sell |
9,712,566
-835,636
| -8% | -$7.76M | 0.01% | 1237 |
|
|
2023
Q1 | $99.2M | Buy |
10,548,202
+511,825
| +5% | +$6.04M | 0.01% | 1192 |
|
|
2022
Q4 | $123M | Sell |
10,036,377
-4,602
| -0% | -$57.4K | 0.01% | 1047 |
|
|
2022
Q3 | $125M | Sell |
10,040,979
-2,159,202
| -18% | -$37.7M | 0.01% | 983 |
|
|
2022
Q2 | $239M | Sell |
12,200,181
-374,502
| -3% | -$8.86M | 0.01% | 672 |
|
|
2022
Q1 | $328M | Sell |
12,574,683
-1,317
| -0% | -$35.1K | 0.02% | 647 |
|
|
2021
Q4 | $357M | Buy |
12,576,000
+595,779
| +5% | +$18.5M | 0.02% | 630 |
|
|
2021
Q3 | $382M | Sell |
11,980,221
-144,140
| -1% | -$4.84M | 0.02% | 596 |
|
|
2021
Q2 | $421M | Sell |
12,124,361
-2,084,650
| -15% | -$68.8M | 0.02% | 586 |
|
|
2021
Q1 | $418M | Sell |
14,209,011
-1,609,649
| -10% | -$49.5M | 0.02% | 562 |
|
|
2020
Q4 | $485M | Buy |
15,818,660
+1,352,492
| +9% | +$41.3M | 0.03% | 480 |
|
|
2020
Q3 | $404M | Sell |
14,466,168
-300,040
| -2% | -$7.6M | 0.03% | 480 |
|
|
2020
Q2 | $317M | Buy |
14,766,208
+2,126,381
| +17% | +$47M | 0.02% | 537 |
|
|
2020
Q1 | $283M | Buy |
12,639,827
+2,472,266
| +24% | +$67.7M | 0.02% | 512 |
|
|
2019
Q4 | $299M | Buy |
10,167,561
+404,210
| +4% | +$11M | 0.02% | 589 |
|
|
2019
Q3 | $260M | Buy |
9,763,351
+3,087,565
| +46% | +$92.6M | 0.02% | 611 |
|
|
2019
Q2 | $226M | Buy |
6,675,786
+765,362
| +13% | +$24.8M | 0.02% | 659 |
|
|
2019
Q1 | $190M | Buy |
5,910,424
+4,727,150
| +399% | +$145M | 0.01% | 694 |
|
|
2018
Q4 | $37.3M | Buy |
1,183,274
+1,056,080
| +830% | +$34.6M | ﹤0.01% | 1546 |
|
|
2018
Q3 | $4.44M | Buy |
+127,194
| New | +$4.47M | ﹤0.01% | 2911 |
|
Other funds holding ELAN
BCIM
State Street's ELAN Position: Q2 2026 in Review
State Street increased its Elanco Animal Health (ELAN) stake by 4.7% in Q2 2026, buying an estimated $16.8M and bringing the position to 16,063,046 shares worth $395M. The position accounts for 0.01% of the portfolio, ranked #686.
State Street first reported a position in ELAN in Q3 2018 and has held it in 32 quarters since. The position peaked at $485M in Q4 2020. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.
- State Street held 16,063,046 shares of Elanco Animal Health worth $395M as of Q2 2026.
- State Street bought 726,567 Elanco Animal Health shares in Q2 2026, an estimated $16.8M.
- Elanco Animal Health made up 0.01% of State Street's portfolio in Q2 2026, its #686 holding.
- State Street first reported a position in Elanco Animal Health in Q3 2018 and has held it in 32 quarters since.
- State Street's Elanco Animal Health position peaked at $485M in Q4 2020.
- 520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.